New Delhi: As more and more states flag shortage of COVID-19 vaccine doses, the Central government has pressed the accelerator to scale up vaccine production manifold.Top government sources told ANI that by end of the third quarter of this year, India will be getting vaccines from five additional manufacturers.
India currently manufactures Covishield and Covaxin.Explaining the new strategy to manufacture additional vaccine doses, a source said "India currently has 2 COVID-19 vaccines being manufactured locally: Covishield and Covaxin, and we can expect five more vaccines by Q3 2021.
These vaccines are Sputnik V vaccine (in collaboration with Dr. Reddy's), Johnson & Johnson vaccine (in collaboration with Biological E), Novavax vaccine (in.